Founder Haus’ Post

#thoughtfulthursday: Our Founder and Director, Dr Sudha Rao, shares a powerful reminder: Every entrepreneur in the genomics industry must keep an ear to the ground, staying deeply attuned to the ever-evolving landscape of science and society. By grounding your vision and ambition in reality, you not only drive meaningful innovation but also create solutions that truly impact lives. Success in genomics isn’t just about breakthroughs; it’s about understanding and aligning with the pulse of human needs and scientific progress. 🌱🔬 #GenomicsLeadership #InnovationWithPurpose #VisionToImpact #GenomicsForGood #BiotechEntrepreneurs #PrecisionMedicine #FutureOfGenomics #ScientificLeadership #HealthcareInnovation #GenomicsRevolution #EntrepreneurshipInScience #TransformingHealth #GroundedInnovation #ScienceAndSociety #GenomicsPioneers

This week Kevin J. Prince and I attended an entrepreneurship workshop by the Helmholtz-Gemeinschaft / Helmholtz Association and ASPER-HUJI Innovate . Special thanks to Sharon Levite-Vaknin and Amnon Dekel, PhD for making it so insightful and engaging! What was unique was that all participants were researchers from various Helmholtz centres. Naturally, most ideas were based on visionary research topics and if successful, had the potential to change the world in areas such as solar power, farming in vast oceans, spotting deep fakes, early cancer or epilepsy detection, preventing asthma, treating malaria, and dealing with antibiotic resistance. It was a reminder of why challenging, risky scientific research are well worth the time, effort and public money. I would encourage more researchers among my peers to consider the path of #Impactentrepreneurship because they: 1. have field expertise and; 2. can get encouragement, and flexibility to experiment in their research centres which one will be really hard-pressed to find in a private company. Photographer: Marvin Hönig.

The interview with Uirá Souto Melo provided by our accelerator partner Start2 Group offers a revealing insight into the ground-breaking work of Lucid Genomics.   After the successful participation in MAX!mize of Max-Planck-Innovation GmbH, the outstanding team of Lucid Genomics - a spin-out from the Max-Planck-Institut für Molekulare Genetik - is now part of the first MPF Start-up Accelerator batch. 💡   Lucid Genomics is doing some truly cutting-edge work in the field of genomics - have you heard of them? Their approach to genomic research is not only innovative but has the potential to make a huge impact on healthcare and technology.   If you’re a start-up looking for opportunities to grow and connect with industry leaders, consider joining the next cohort of the MPF Start-up Accelerator! 🚀 The program is designed to empower ambitious companies like Lucid Genomics to scale and succeed.   The accelerator is hosted by the MPF Start-up Accelerator GmbH which is a wholly owned subsidiary of the Max Planck Foundation.   👉 Sign up today and take your business to the next level! https://lnkd.in/gMJKT8yT   Excited to see what’s next for Lucid Genomics! 🌟 #Genomics #AcceleratorProgram #Biotech #FutureOfHealth

Planning to attend the Translational Science Summit by LifeArc? 🌐 Our Biotech Venture Developer, Ankita Das, will be attending the “Translational Science Summit” tomorrow, the 23rd of April, in London. This event will bring together leading scientists, policy makers and innovators to discuss vital topics, such as navigating the funding in biotech ventures, data-driven discoveries, translational science, and accelerating translation for disadvantaged individuals. Don’t miss out to connect with Ankita, to hear more about our biotech projects! #TranslationalScienceSummit  #BiotechVentures #TranslationalScience #LifeArc

🌍 Global Entrepreneurship Week: Ronawk Spotlight We’re kicking off Global Entrepreneurship Week by spotlighting Ronawk, a pioneering NSF-PTRM Engine ecosystem partner in tissue engineering and regenerative medicine! Hear from Ronawk’s CEO and Co-Founder, Dr. A.J. Mellott, as he shares how the collaborative spirit within the NSF-PTRM Engine here in North Carolina creates synergy that accelerates impactful solutions. Founded in 2019, Ronawk has pushed boundaries in regenerative medicine with its advanced BioBlocks™ technology, enabling continuous cell growth in body-like environments. This innovation allows scientists to conduct previously challenging experiments, advancing research and technology applications in new ways. Check out the video to learn more about Ronawk’s vision and its partnership with NSF-PTRM Engine to drive meaningful change! #GlobalEntrepreneurshipWeek #NSFengines #PTRME #Ronawk #Innovation #TissueEngineering

Economic differences may lead to biological disparities, a daunting challenge for tech entrepreneurs. Genofax® Life Sciences #EconomicDifferences #BiologicalDifferences #TechEntrepreneurs #FutureOfTechnology #InnovationChallenges #TechEthics #SocialImpact #TechForGood #GlobalIssues

Looking for your next high-potential investment in life sciences? At Life Science Nation (LSN)'s #RESIConference during #JPM2025 the NIH SEED is showcasing 12 cutting-edge life sciences companies that stand out from the crowd. Here’s what makes them prime investment opportunities: 🔹 De-risked through rigorous scientific review – Backed by the NIH for their innovation and potential. 🔹 Non-dilutive funding secured – Giving them a strong foundation for growth. 🔹 Groundbreaking innovations – At the forefront of biotech, tackling some of the biggest challenges in health and medicine. These companies are positioned for success, but the window to invest in them won’t stay open for long. If you’re serious about finding your next investment in life sciences, you can’t afford to sit this one out. Girish K. of Arborsense, Inc., Donna J. Edmonds of BRAINBox Solutions, Inc. , Marlee Krieger of Calla Health Foundation, Rachel Kuperman of Eysz, Chengcang Wu of Intact Genomics, Inc., Marc Finch of #Pretel, Roarke Horstmeyer and Gregor Horstmeyer of #Romana, Sergio Barberan-Soler and Anne Scholz of RealSeq Biosciences, Anna Lisa Somera of Rhaeos, Michael Giles of Sonara Health, Negin Majedi, PhD of Symphony Biosciences, and Tim Keane of TYBR Health Learn more about these 12 companies at https://lnkd.in/eZnXCqkt ♻️ Share this post to make sure others in your network don’t miss out. Ethel Rubin John Sullivan Anna Zornosa Luis Gutiérrez John P. Reinhart Kuldeep Neote Stephen Flaim, Ph.D., FACC, FAHA Chris S. Olivia Meyer Brittany Connors, PMP Jessica Lukacs, MD, MBA, Emily Caporello Bluvas Dennis Ford Max Braht

💵 Funding News: clock.bio Raises $5.3M to Unlock the Secrets of Cellular Rejuvenation! 💥 Cambridge-based clock.bio is on a mission to redefine healthspan with groundbreaking biotech solutions! Here’s how they’re moving the needle on age-related diseases: Funding Details: 🔸Raised: $5.3M Seed Round 🔸Led by: LocalGlobe, with BlueYard Capital, Onsight Ventures, & Dr. Jonathan Milner What’s Next? 🔹Atlas of Rejuvenation Factors 🔬: Building a comprehensive guide of genes to target for rejuvenation. 🔹Validation & Prioritization ✅: Fine-tuning their target list for clinical development. Under the leadership of CEO Markus Gstöttner, CTO Rodrigo Santos, and Chairman Mark Kotter, clock.bio is combining CRISPR and single-cell RNA sequencing to unlock how human cells naturally rejuvenate, pinpointing over 100 critical genes. 💡 Why It Matters: By translating insights from the body’s own rejuvenation process, clock.bio aims to extend healthspan and develop therapies to combat age-related diseases, paving the way for a healthier, longer life. Let’s build a future where we age gracefully—powered by cutting-edge science! 🚀 📢 Stay tuned to Future Techly for the latest updates on this groundbreaking initiative and the latest in tech and business! 💥 Source: FinSMEs ♻️ Repost if you think this insight is worth sharing!

🚨 New Episode Alert! 🎙️ Today, James Zanewicz, JD, LLM, RTTP is joined by the inspiring Wendy Overton from Endios Bio! 🌟 Wendy takes us on her 15-year journey as a trailblazing woman entrepreneur, and how she started in the life sciences industry. 💼💡 Wendy discusses a groundbreaking discovery made by her collaborating scientist: a new druggable target for ALS (Amyotrophic Lateral Sclerosis). 🧠💊 Her mission now is to advance this discovery into clinical trials. 🚀 Staying true to her mantra, "Find Someone, Help Them, Repeat," Wendy and her team are actively seeking funding 💰 to move this discovery forward and are looking to network with life science experts 🧬 who can contribute to this innovative work. ► Learn more about *Bio on the Bayou*: www.bioonthebayou.com 📆 Save the Date for BotB2025: October 28-29, 2025 ► More about Bullpen Club: https://bullpen.ventures/ 📆 Upcoming Event: JPM Week in San Francisco, January 13-16, 2025 https://lnkd.in/gWvG5CfD 🌟 A special thank you to our sponsors: 🌟 D3 Digital Media Marketing, Bullpen, Louisiana State University Health Sciences Center, Auburn University, University of Mississippi Tulane University School of Medicine, Xavier University of Louisiana, James Zanewicz, JD, LLM, RTTP. #Bullpen #Networking #Collaboration ✨ #BioOnTheBayou #InnovationInAction🌟 #USA #Innovation #BullpenCommunity #Entrepreneurship #TulaneUniversity #UniversityOfMississippi

I recently had the pleasure of interviewing research scientist Johnathon Anderson, whose company, Peptide Systems, is paving the way for groundbreaking therapies. Check out Copybrighters' blog post to learn more about his inspiring story and the great potential of peptides (small proteins) in biomedical research.